3 Further information

3.1

This guidance requires that clinicians undertaking the procedure make special arrangements for audit. NICE has developed an audit tool (which is for use at local discretion).

3.2

NICE has produced technology appraisal guidance on cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy.